2-190999712-C-G

Variant names:

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007315.4(STAT1):c.463-8G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000562 in 1,604,434 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 32)

Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

STAT1
NM_007315.4 splice_region, intron

Scores

Splicing: ADA: 0.00002294

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.149

Publications

1 publications found

Variant links:

Genes affected

STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]

STAT1 Gene-Disease associations (from GenCC):

autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
immunodeficiency 31B
Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

STAT1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.81).

BP6

Variant 2-190999712-C-G is Benign according to our data. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-190999712-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 541828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BS1

Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.003 (456/152116) while in subpopulation AFR AF = 0.0107 (445/41490). AF 95% confidence interval is 0.0099. There are 2 homozygotes in GnomAd4. There are 214 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

BS2

High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
STAT1	NM_007315.4 link	c.463-8G>C		splice_region_variant, intron_variant	Intron 6 of 24	ENST00000361099.8	NP_009330.1	P42224-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
STAT1	ENST00000361099.8 link	c.463-8G>C		splice_region_variant, intron_variant	Intron 6 of 24	1	NM_007315.4	ENSP00000354394.4		P42224-1

Frequencies

GnomAD3 genomes

AF:

0.00300

AC:

456

AN:

151998

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0108

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.000459

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000147

Gnomad OTH

AF:

0.00143

GnomAD2 exomes

AF:

0.000717

AC:

180

AN:

250924

AF XY:

0.000590

show subpopulations

Gnomad AFR exome

AF:

0.0106

Gnomad AMR exome

AF:

0.000174

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000176

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.000307

AC:

446

AN:

1452318

Hom.:

Cov.:

AF XY:

0.000252

AC XY:

182

AN XY:

723114

show subpopulations

African (AFR)

AF:

0.0118

AC:

391

AN:

33268

American (AMR)

AF:

0.000246

AC:

AN:

44712

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26066

East Asian (EAS)

AF:

0.00

AC:

AN:

39646

South Asian (SAS)

AF:

0.0000116

AC:

AN:

86056

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53220

Middle Eastern (MID)

AF:

0.000174

AC:

AN:

5746

European-Non Finnish (NFE)

AF:

0.00000634

AC:

AN:

1103514

Other (OTH)

AF:

0.000582

AC:

AN:

60090

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.451

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

100

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.00300

AC:

456

AN:

152116

Hom.:

Cov.:

AF XY:

0.00288

AC XY:

214

AN XY:

74368

show subpopulations

African (AFR)

AF:

0.0107

AC:

445

AN:

41490

American (AMR)

AF:

0.000458

AC:

AN:

15282

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5178

South Asian (SAS)

AF:

0.00

AC:

AN:

4820

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10558

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.0000147

AC:

AN:

67998

Other (OTH)

AF:

0.00142

AC:

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.495

Heterozygous variant carriers

114

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00100

Hom.:

Bravo

AF:

0.00366

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:3

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

STAT1-related disorder

Benign:1

Jul 08, 2019

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Immunodeficiency 31B;C3279990:Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome;C4013950:Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency

Benign:1

Feb 02, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:1

Nov 01, 2024

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

STAT1: BP4, BS1 -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.81

CADD

Benign

2.4

(source)

DANN

Benign

0.46

PhyloP100

-0.15

Mutation Taster

=100/0

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

dbscSNV1_ADA

Benign

0.000023

dbscSNV1_RF

Benign

0.0040

SpliceAI score (max)

0.060

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over